Live Breaking News & Updates on Avanir Pharmaceuticals|Page 3

Stay updated with breaking news from Avanir pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer - Madrigal Pharmaceuticals (NASDAQ:MDGL)

CONSHOHOCKEN, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today ....

Julian Baker , Sanofi Genzyme , Alex Howarth , Paul Friedman , Lycera Corp , Avanir Pharmaceuticals , Sanofi Executive Committee , Harvard Business School , Yale University , Madrigal Pharmaceuticals Inc , Madrigal Pharmaceuticals , Exchange Commission , Bill Sibold , Chief Executive Officer , Executive Vice President , Specialty Care , Sanofi North America , Rare Disease , Rare Blood Disorders , Sanofi Executive , Sanofi Specialty Care , Global Business , Senior Vice President , Global Franchise Head , Multiple Sclerosis , Global Franchise Head Multiple ,

CG Oncology Raises $105M for Bladder Cancer Work - Orange County Business Journal

CG Oncology Inc., an Irvine-based cancer research firm that says it’s making “significant clinical progress” on bladder cancer treatments, this month announced the close of an oversubscribed $105 million crossover financing round. ....

United States , Andrea Maddox Smith , Arthur Kuan , Giuliano Marostica , Johns Hopkins University , Malin Corporation , Avanir Pharmaceuticals , National Cancer Institute , Bladder Cancer Advocacy Network , Spectrum Center , Cg Oncology Inc , Foresite Capital , Orange County , National Cancer , San Francisco Based Foresite Capital , Avidity Partners , Janus Henderson Investors , Acorn Bioventures , Ally Bridge Group , Decheng Capital , Longitude Capital , North America , Bladder Cancer Advocacy ,

Longeveron Announces Key Additions To Its Leadership Team and Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions

By David Willey, BenzingaLongeveron, Inc. is a clinical-stage biopharmaceutical company focused on therapies for age-related and life-threatening diseases. Longeveron’s primary drug is. ....

Jeffrey Pfeffer , Khoso Baluch , Lisa Locklear , Nataliya Agafonova , Eli Lilly , Christine Petraglia , David Willey , Stanford University Graduate School Of Business , National Association Of Corporate Directors , Exchange Commission , Cormedix Inc , Longeveron Inc , Other Team Appointments , Company Website , Avanir Pharmaceuticals , Board Member , Wa El Hashad , Chief Executive Officer , University Graduate School , Chief Medical Officer , Executive Vice President , Chief Financial Officer , Corporate Directors , Looking Statementscertain , Private Securities Litigation Reform Act , Annual Report ,

Trevena, Inc. Appoints Mark Corrigan to Board of Directors

Trevena, Inc. announced that Mark Corrigan, M.D. has been appointed to the Companys Board of Directors, effective July 18 2023. Dr. Corrigan is a highly successful pharmaceutical executive with more. ....

United States , Mark Corrigan , Board Of Directors Cubist Pharmaceuticals , Correvio Pharma Corp , Maine Medical Center , Department Of Psychiatry At Brigham , Research Development Of Tremeau , Scientific Advisory Committee Of Avanir Pharmaceuticals , Trevena Inc , Tremeau Pharmaceuticals , Cornell University , Wave Life Sciences , University Of Virginia , Companys Board , Chief Executive Officer , Elios Therapeutics , Nabriva Therapeutics , Wave Life , Womens Hospital , Cubist Pharmaceuticals , Scientific Advisory Committee , Avanir Pharmaceuticals ,

Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors

Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Bob Yoder , Mark Corrigan , Carrie Bourdow , Department Of Psychiatry At Brigham , Company Board Of Directors , Scientific Advisory Committee Of Avanir Pharmaceuticals , Wave Life Sciences , Cornell University , Company Annual Report On Form , Trevena Inc , Company Contact , University Of Virginia , Exchange Commission , Dan Ferrymanaging Directorlifesci Advisors , Tremeau Pharmaceuticals , Maine Medical Center , Board Of Directors Cubist Pharmaceuticals , National Institutes Of Health , Correvio Pharma Corp , Research Development Of Tremeau , Business Officertrevena Inc , Chief Executive Officer , Elios Therapeutics , Nabriva Therapeutics , Wave Life ,